The present invention relates to new compounds that show pharmacological dual activity towards the subunit α 2 δ of voltage-gated calcium channels (VGCC), especially the α 2 δ-1 subunit of voltage-gated calcium channels, and the μ-opiod receptor (MOR or mu-opioid). The invention is also related to the process for the preparation of said compounds as well as to compositions comprising them, and to their use as medicaments.本發明關於對電位閘控鈣通道(Voltage-gated calcium channels,VGCC)之亞基α 2 δ，尤其是電位閘控鈣通道的α 2 δ-1亞基，和μ-類鴉片受體(MOR或μ-類鴉片)顯示出藥理雙重活性之新化合物。本發明還關於用於製備所述化合物之方法和包含所述化合物之組成物以及它們作為藥劑之用途。
